| 序号 | 英文主题词 | 中文主题词 | 命中文献数量（篇） |
|---|
| 期刊 | 博硕士论文 | 会议论文 | 报纸 | 年鉴 | 成果 | 专利 | 国家标准 | 行业标准 | 标准 | 总计 | | 261 | Reality Therapy | 现实治疗 | 7 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | | 262 | Reasonable Collection | 合理采挖 | 6 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | | 263 | Reassortant Viruses | 再装配病毒 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 264 | Rec A Recombinases | Rec A重组酶 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | | 265 | Receptaculum Nelumbinis | 莲房 | 117 | 5 | 6 | 14 | 0 | 0 | 1 | 0 | 0 | 0 | 143 | | 266 | Receptor Activator of Nuclear Factor-kappa B | κB核因子激活受体 | 22 | 1 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 27 | | 267 | Receptor Activity-Modifying Protein 1 | 受体活性修饰蛋白1 | 8 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | | 268 | Receptor Activity-Modifying Protein 2 | 受体活性修饰蛋白2 | 5 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | | 269 | Receptor Activity-Modifying Protein 3 | 受体活性修饰蛋白3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | | 270 | Receptor Activity-Modifying Proteins | 受体活性修饰蛋白类 | 53 | 3 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68 | | 271 | Receptor Aggregation | 受体聚集 | 10 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 12 | | 272 | Receptor Cross-Talk | 交叉感知受体 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | | 273 | Receptor Protein-Tyrosine Kinases | 受体蛋白质酪氨酸激酶 | 8422 | 503 | 702 | 190 | 55 | 46 | 56 | 0 | 0 | 0 | 9974 | | 274 | Receptor Tyrosine Kinase-like Orphan Receptors | 受体酪氨酸激酶样孤儿受体 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | | 275 | Receptor, Adenosine A1 | 受体, 腺苷A1 | 66 | 9 | 8 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 85 | | 276 | Receptor, Adenosine A2A | 受体, 腺苷A2A | 34 | 6 | 2 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 44 | | 277 | Receptor, Adenosine A2B | 受体, 腺苷A2B | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | | 278 | Receptor, Adenosine A3 | 受体, 腺苷A3 | 14 | 1 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 20 | | 279 | Receptor, Anaphylatoxin C5a | 受体, 过敏毒素C5a | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | | 280 | Receptor, Angiotensin, Type 1 | 受体, 血管紧张素, 1型 | 631 | 38 | 29 | 6 | 1 | 5 | 3 | 0 | 0 | 0 | 713 |
|
|